In this PharmExec.com article, "Barrier to Generic Competition Threatens Safe, Low Cost Drug Options," Carlos Angulo and Sasha Miller argue that an increasingly common pharmaceutical brand company tactic is threatening to undermine the entire FDA generic drug approval process.
